Full-Time

VP – Machine Learning

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Applied Machine Learning
Deep Learning
AI & Machine Learning
Required Skills
Data Science
Machine Learning
Operations Research

You match the following Flagship Pioneering's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Ph.D. in machine learning, statistics, computer science, mathematical modeling, operations research, or related field computational chemistry, or other highly-technical fields from a recognized higher-education establishment
  • 3-10 years of experience in the area of computational science and artificial intelligence with a track record of solving real-world problems
  • Demonstrated mastery of a broad array of machine learning and deep learning approaches across a variety of architectures and libraries
  • Proven ability to innovate on generative machine learning models with novel architectures
  • Demonstrated ability to interface with, communicate with, and motivate diverse teams of domain experts
  • Excellent oral and written communication skills, for both technical and more general audiences
Responsibilities
  • Develop the vision and strategic plan for FL94’s machine learning platform, driving novel discoveries in small molecule chemistry
  • Build and lead the data science team translating small molecule and proteomic drug discovery challenges into breakthroughs via deep learning
  • Own the philosophy and strategy behind core machine learning technology and applications
  • Develop a robust data portal that will enable the application of generative models to proprietary chemoproteomics data
  • Define team mission and propose org structure and interaction model to ensure for successful execution
  • Oversee the development and prototyping of novel ML algorithms for drug discovery problems
  • Ensure effective training and validation of large deep learning models at scale
  • Identify and act upon new areas of applied research that can further the platform’s ability to have therapeutic impact
  • Work collaboratively in cross-functional chemistry, proteomics, drug discovery and AI/machine learning teams
  • Partner across the organization to align data generation with infrastructure, innovative approaches, and data integration strategies
  • Communicate strategy, R&D progress to leadership & actively engage in outreach to external advisors
  • Prepare and deliver scientific updates to the executive leadership team, board of directors, and company advisors
  • Assemble and manage machine learning and data science Scientific Advisory Boards
  • Embody FL94’s core mission to enable generative design of protein editing chemistries and live and set a culture that is highly resilient, optimistic, innovative, solutions-oriented, transparent, and inclusive
Desired Qualifications
  • Foundational understanding of biology and chemistry, particularly knowledge of chemoproteomics and small molecule drug development is preferred but not required

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.
  • Strategic partnerships with Pfizer enhance drug discovery and development capabilities.
  • Inari Agriculture's $2.17 billion valuation highlights successful investment strategy.

What critics are saying

  • Over-reliance on strategic partnerships with large pharmaceutical companies poses potential risks.
  • High-profile executive appointments may lead to cultural clashes within teams.
  • Focus on first-in-category ventures may result in higher R&D costs and longer profitability timelines.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • Combines innovative capacity, entrepreneurial leadership, and capital management in one enterprise.
  • Uses evolutionary methodology to navigate from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.

Bloomberg
Jan 7th, 2025
Ag Tech Startup Inari Gets $2.17 Billion Valuation in Latest Funding Round

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a roughly 32% jump from a prior mark of $1.65 billion set last January.

Contract Pharma
Nov 21st, 2024
Flagship Pioneering Enters Agreements Under Strategic Pfizer Pact

Flagship Pioneering, a bioplatform company, entered agreements with Ampersand Biomedicines and Montai Therapeutics to identify targeted molecules that could be further developed as treatments for obesity and non-small cell lung cancer (NSCLC).